Fig. 1From: Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trialParticipant flowchart. HBV, hepatitis B virus; HCC, hepatocellular carcinomaBack to article page